GeneQuantum (GQ) is a global innovative biopharmaceutical company and one of the pioneers dedicated to the development of ADC drugs using enzyme-mediated site‑specific conjugation technology. GQ was founded in Suzhou, China in 2013 with about 150 employees covering the R&D, process development, manufacture, clinical, business development, project management departments. We have established comprehensive proprietary technology system, iLDC® and iGDC®, which can provide end-to‑end solutions for development and commercialization of bioconjugate drugs including ADCs. Based on our advanced, unique technology platform, we have successfully developed multiple clinically advanced innovative ADC products. ADCs enabled by GQ’s technologies have shown revolutionized elvation in process quality, metabolic stability, and the intelligent conjugation process can be seamlessly integrated into the antibody process, which significantly reduces the comprehensive CMC cost. GeneQuantum is committed to "empowering" the development of bioconjugate drugs around the world to build a benign, competitive ecosystem for the development of next‑generation ADCs and to achieve win‑win cooperation for the participants, eventually bringing revolutionized, affordable bioconjugate drugs to cancer patients worldwide.
Responsibilities
- Led BD dialogues with potential deal partners, including pharma, large biotech, and non‑profit organizations, and sourced additional deal opportunities through personal networks and conferences.
- Responsible for the end‑to‑end execution of BD strategies, established and led the company’s out‑licensing processes, as deal team lead, led cross‑functional due diligence efforts involving Clinical, Preclinical, CMC, Finance, Legal, Commercial, and Quality Assurance teams.
- Working closely with C‑level executives to formulate corporate BD strategies, and, at the request of the Board of Directors, developed and presented capital raising, business development, and commercialization strategies.
- Cultivated strong relationships with potential deal partners, leading correspondence and coordinating meetings with C‑level executives and key decision makers throughout the deal process.
- Evaluated new discovery programs based on strategic fit and commercial attractiveness; co‑led corporate strategy and long‑range planning initiatives, and built/maintained financial models.
- Contributed to financing document preparation, coordinated due diligence activities, and regularly presented updates to C‑level executives.
Qualifications
- Master's degree or above, preferably in a biopharmaceutical‑related field.
- Minimum 6 years of business development experience in the biopharmaceutical industry, including at least 3 years in team management or global BD leadership, with a proven track record of leading major cross‑border transactions such as out licensing, joint ventures, and M&A.
- Global communication and perspective: Proficient in English as a working language, capable of engaging effectively with international partners.
- Adaptable to the fast‑paced, high‑risk, and long cycle nature of the biopharmaceutical industry; able to identify opportunities amid uncertainty, drive strategy execution, and deliver on performance goals.
Seniority level: Director
Employment type: Full‑time
Job function: Business Development
Industries: Pharmaceutical Manufacturing
#J-18808-Ljbffr